Genetic Testing Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	126 Pages	Global Market Insights	November, 2024	GMI19407251

Best Price Guarantee
Price	from $4,850
Length	126 Pages
Publisher	Global Market Insights
Published Date	November, 2024
SKU	GMI19407251

Genetic Testing Market

The Global Genetic Testing Market was valued at USD 18.6 billion in 2023 and is projected to grow at a robust CAGR of 12.3% between 2024 and 2032. This growth is driven by advancements in genomics, such as high-throughput sequencing technologies and enhanced bioinformatics tools, which have significantly improved the accuracy, efficiency, and affordability of genetic testing. Additionally, the integration of genetic testing with digital health platforms and electronic health records has made genetic information more accessible and actionable, enhancing its utility in both clinical and consumer health settings.

The increasing availability of consumer-initiated genetic testing services and products is also contributing to market growth. These services provide individuals with personalized insights into their genetic health risks, making genetic information more user-friendly and supported by tools like personalized health reports and access to genetic counseling. Further, ongoing research funding aimed at accelerating technological innovation in the genomics sector is expected to drive continued expansion in the genetic testing industry.

In terms of products and services, the market is segmented into kits & reagents and software & services. The kits & reagents segment dominated the market in 2023, generating USD 12.1 billion in revenue. Next-generation sequencing (NGS) kits, in particular, are in high demand due to their ability to sequence entire genomes or specific regions, facilitating comprehensive genetic analysis. These kits are critical for both clinical diagnostics and research, offering reagents for processes such as library preparation, sequencing, and data analysis.

When classified by test type, the market includes predictive testing, carrier testing, prenatal & newborn testing, diagnostic testing, pharmacogenomics, nutrigenomics, and others. The prenatal and newborn testing segment led the market with a 39.6% share in 2023. This segment's dominance is driven by the growing adoption of advanced screening methods, such as non-invasive prenatal testing (NIPT), which allow for early detection of genetic disorders without the risks associated with invasive procedures.

Regionally, North America held the largest market share, accounting for 46.3% in 2023. The region’s dominance is supported by a strong presence of key market players, advanced healthcare infrastructure, and leading research institutions focused on genetic research. High levels of awareness about genetic disorders and their treatment options also drive the demand for genetic testing services and products in North America, positioning it as a key player in the global market growth trajectory.

Chapter 1 Methodology: 1.1 Market segmentation; 1.2 Market definitions; 1.3 Research design; 1.4 Market size estimates and calculations; 1.4.1 Approach 1: Revenue share analysis; 1.4.2 Approach 2: Data mining approach; 1.4.3 Approach 3: Volume analysis; 1.5 Key trends for market estimates; 1.6 Forecast model; 1.7 Primary research & validation; 1.7.1 Primary sources; 1.7.2 Data mining sources; 1.7.2.1 Paid sources; 1.7.2.2 Public sources
Chapter 2 Executive Summary: 2.1 Industry landscape, 2021 - 2032 (USD Bn); 2.1.1 Business trends; 2.1.2 Regional trends; 2.1.3 Product & services trends; 2.1.4 Test type trends; 2.1.5 Application trends; 2.1.6 Techniques trends; 2.1.7 End-use trends
Chapter 3 Industry Insights: 3.1 Industry ecosystem analysis; 3.2 Industry impact forces; 3.2.1 Growth drivers; 3.2.1.1 Technological advancement and availability of new tests; 3.2.1.2 Growing application of genetic testing in oncology and genetic diseases; 3.2.1.3 Increasing consumer preference for personalized medicine; 3.2.2 Industry pitfalls; 3.2.2.1 High cost of genetic testing; 3.2.2.2 Dearth of experienced professionals and advanced infrastructure in developing economies; 3.3 Growth potential analysis; 3.3.1 By products & services; 3.3.2 By test type; 3.3.3 By application; 3.3.4 By techniques; 3.3.5 By end-use; 3.4 Regulatory landscape; 3.4.1 U.S.; 3.4.2 Europe; 3.5 Technology landscape; 3.6 Reimbursement scenario; 3.7 Porter's analysis; 3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023: 4.1 Introduction; 4.1.1 Abbott Laboratories; 4.1.2 Illumina, Inc.; 4.1.3 Siemens Healthineers AG; 4.2 Company market share analysis; 4.3 Company matrix analysis; 4.4 Competitive analysis of major market players; 4.5 Competitive positioning matrix; 4.6 Strategy dashboard
Chapter 5 Genetic Testing Market, By Products & Services: 5.1 Kits & reagents; 5.2 Software & services
Chapter 6 Genetic Testing Market, By Test Type: 6.1 Predictive testing; 6.2 Carrier testing; 6.3 Prenatal and newborn testing; 6.4 Diagnostic testing; 6.5 Pharmacogenomic testing; 6.6 Nutrigenomic testing; 6.7 Other test types
Chapter 7 Genetic Testing Market, By Application: 7.1 Cancer treatment; 7.2 Tissue typing for transplantation; 7.3 Forensic identity testing; 7.4 Ancestry testing; 7.5 Paternity testing; 7.6 Other applications
Chapter 8 Genetic Testing Market, By Techniques: 8.1 Polymerase chain reaction; 8.2 DNA sequencing; 8.2.1 Sanger sequencing; 8.2.2 Next generation sequencing; 8.3 Cytogenetic testing; 8.3.1 Chromosome analysis (karyotyping); 8.3.2 Fluorescence in situ hybridization (FISH); 8.4 Microarrays; 8.5 Gene expression profiling
Chapter 9 Genetic Testing Market, By End-use: 9.1 Hospitals & clinics; 9.2 Diagnostic laboratories; 9.3 Forensic laboratories; 9.4 Other end-users
Chapter 10 Genetic Testing Market, By Region: 10.1 North America; 10.2 Europe; 10.3 Asia Pacific; 10.4 Latin America; 10.5 Middle East and Africa
Chapter 11 Company Profiles: 11.1 23 and ME, Inc.; 11.1.1 Global overview; 11.1.2 Business overview; 11.1.3 Financial data; 11.1.3.1 Annual sales revenue, 2020-2023 (USD Million); 11.1.4 Product landscape; 11.1.5 Strategic outlook; 11.1.6 SWOT analysis; 11.2 Abbott Laboratories; 11.2.1 Global overview; 11.2.2 Business overview; 11.2.3 Financial data; 11.2.3.1 Annual sales revenue, 2020-2023 (USD Million); 11.2.4 Product landscape; 11.2.5 SWOT analysis; 11.3 Ambry Genetics (Konica Minolta); 11.3.1 Global overview; 11.3.2 Business overview; 11.3.3 Financial data; 11.3.3.1 Annual sales revenue, 2020-2023 (USD Million); 11.3.4 Product landscape; 11.3.5 SWOT analysis; 11.4 Ancestry DNA; 11.4.1 Global overview; 11.4.2 Business overview; 11.4.3 Financial data; 11.4.3.1 Annual sales revenue, 2023 (USD Million); 11.4.4 Product landscape; 11.4.5 SWOT analysis; 11.5 BioMerieux SA; 11.5.1 Global overview; 11.5.2 Business overview; 11.5.3 Financial data; 11.5.3.1 Annual sales revenue, 2020-2023 (USD Million); 11.5.4 Product landscape; 11.5.5 SWOT analysis; 11.6 BGI Genomics Co., Ltd.; 11.6.1 Global overview; 11.6.2 Business overview; 11.6.3 Financial data; 11.6.4 Product landscape; 11.6.5 SWOT analysis; 11.7 Illumina, Inc.; 11.7.1 Global overview; 11.7.2 Business overview; 11.7.3 Financial data; 11.7.3.1 Annual sales revenue, 2020-2023 (USD Million); 11.7.4 Product landscape; 11.7.5 Strategic outlook; 11.7.6 SWOT analysis; 11.8 Invitae Corporation; 11.8.1 Global overview; 11.8.2 Business overview; 11.8.3 Financial data; 11.8.3.1 Annual sales revenue, 2020 - 2023 (USD Million); 11.8.4 Product landscape; 11.8.5 SWOT analysis; 11.9 Luminex Corporation (DiaSorin); 11.9.1 Global overview; 11.9.2 Business overview; 11.9.3 Financial data; 11.9.3.1 Annual sales revenue, 2020-2023 (USD Million); 11.9.4 Product landscape; 11.9.5 SWOT analysis; 11.10 Myriad Genetics, Inc.; 11.10.1 Global overview; 11.10.2 Business overview; 11.10.3 Financial data; 11.10.3.1 Annual sales revenue, 2020 - 2023 (USD Million); 11.10.4 Product landscape; 11.10.5 Strategic outlook; 11.10.6 SWOT analysis; 11.11 Natera, Inc.; 11.11.1 Global overview; 11.11.2 Business overview; 11.11.3 Financial data; 11.11.3.1 Annual sales revenue, 2020 - 2023 (USD Million); 11.11.4 Product landscape; 11.11.5 Strategic outlook; 11.11.6 SWOT analysis; 11.12 QIAGEN N.V.; 11.12.1 Global overview; 11.12.2 Business overview; 11.12.3 Financial data; 11.12.3.1 Annual sales revenue, 2020 - 2023 (USD Million); 11.12.4 Product landscape; 11.12.5 Strategic outlook; 11.12.6 SWOT analysis; 11.13 Quest Diagnostics, Inc.; 11.13.1 Global overview; 11.13.2 Business overview; 11.13.3 Financial data; 11.13.3.1 Annual sales revenue, 2020 - 2023 (USD Million); 11.13.4 Product landscape; 11.13.5 SWOT analysis; 11.14 Siemens Healthineers AG; 11.14.1 Global overview; 11.14.2 Business overview; 11.14.3 Financial data; 11.14.3.1 Annual sales revenue, 2019 - 2022 (USD Million); 11.14.4 Product landscape; 11.14.5 Strategic outlook; 11.14.6 SWOT analysis